Glowing Feedback for the 2nd Annual Peptides Congress

On the 20 th & 21 st April 2015 in London, Oxford Global’s 2 nd Annual Peptides Congress brought together over 300 professionals working within the Peptides and Biotherapeutics industries.Co-located with the 8 th Annual Proteins & Antibodies Congress and 3 rd Annual Biosimilars &Biobetters Congress, the two days allowed all of our delegates and sponsors to attend over 40 presentations, panel discussions and case studies focusing on enabling technologies for peptide screening, synthesis and modification, and peptide formulation and delivery. Delegates were also provided with the opportunity to network with industry leaders and solution providers in both formal
and informal sessions.

Presentations included:
 •  Enteroendocrine Peptide Drug Discovery For Treatment Of Metabolic Diseases: Paul Feldman, Senior Vice President Enteroendocrine DPU, GlaxoSmithKline
 •  PTG-100: An Oral α4β7 Integrin Peptide Antagonist For Treatment Of Ulcerative Colitis: Ashok Bhandari, Senior Director Chemistry, Protagonist Therapeutics
 •  Engineering Peptide Inhibitors Of PCSK9 For LDL Cholesterol Lowering: Daniel Kirchhofer, Principal Scientist, Early Discovery Biochemistry, Genentech
 •  Recent Progress In The Development Of Long Acting GLP-1 R Agonists For The Treatment Of Diabetes & Obesity: Michael Wagner, Head of Peptides, R&D Diabetes Division, Sanofi

We would like to thank all delegates and sponsors for providing us with testimonials from across the 2 days.
Delegate Testimonials for 2015 included:
“Excellent congress. The organisation, staff, and venue were all excellent. I enjoyed the networking drinks, and while my focus was on the peptides I enjoyed the fact I could access all areas.”
Senior R&D Manager, Macphie of Glenbervie

“There was a good selection of solution providers, and a broad spectrum of topics. There were also lots of opportunities for meeting and discussions.”
Director, Preclinical Development, Affibody AB

“The presentations really were excellent. They demonstrated very well the depth and rigour of research that can go on in the pharma industry today. The organisation was really good and you have excellent  staff. I loved the workshop too!”
Associate Director, Pfizer

Sponsor Testimonials for 2015 included:
“The congress had huge networking opportunities; there was plenty of hands-on industry experience.”
Business Development Manager, Metanomics Health GmbH

“The organisation was well above average. The duration of the congress and the exhibition areas were excellent, as was the quality of the speakers.”
CEO, CHELATEC

“Good footfall to the booth and good leads for our Wokingham site. Thanks for your professional administration of the event- see you next time!”
Sales Manager, SGS

Following the event, we analyse statistics and feedback from attendees, and we are proud to announce  that we achieved an “Above Average” or “Excellent” rating in all categories including:
 •  Relevance and Quality of the Delegates and Solution Providers
 •  Organisation of the One-to-one Meetings
 •  Format and Content of the Congress Agenda

This is great news for everyone involved in the production of the 2 nd Annual Peptides Congress.

Oxford Global will shortly start production on the 3 rd Annual Peptides Congress, again co-located with the 9 th Annual Proteins & Antibodies Congress and the 4 th Annual Biosimilars & Biobetters Congress.For further information on attending or sponsoring the event, please contact Steph Punfield on +44 (0)1865 248455 or by email on s.punfield@oxfordglobal.co.uk.